(2S,3S)-3-(tert-Butyl)-4-(2,6-dimethoxyphenyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 1g

1-(2-Chloropyridin-3-yl)-2,2,2-trifluoroethanone, 95+%, 1g

1,5-Dimethyl-1H-indazole-6-boronic acid, 95.0%, 500mg

[2-(1-adamantyl)ethyl]ethylamine hydrochloride, 95.0%, 250mg

4-oxo-1-adamantyl acetate, 95.0%, 10g

Polystyrene Resin cross-linked with 1% DVB (200-400mesh)25g

1-(diazyn-1-ium-1-yl)-16-oxo-16-(2,3,4,5,6-pentafluorophenoxy)-4,7,10,13-tetraoxa-1-azahexadecan-1-ide, 95%, 100mg

Ginsenoside Rb1>95.0%(HPLC)(qNMR)50mg

3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-METHYL 5-[(1-OXOBUTOXY)METHYL] ESTER, 97%, 1g

1-[3-(3,4-Dimethoxyphenyl)propanoyl]piperidine-4-carboxylic acid, 95%, 5g

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(piperazin-1-yl)propoxy)quinazolin-4-amine, 97%, 250mg

O1-Benzyl O3-methyl 3-fluoropyrrolidine-1,3-dicarboxylate, 98%, 100mg

N7,N7-Dimethyl-3-(3-methylphenyl)-1,7-isoquinolinediamine, 98%, 100mg